- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03320148
Determining the Impact of a New Physiotherapist Led Primary Care Model for Back Pain
21 mars 2019 uppdaterad av: Jordan Miller, PT, PhD, Queen's University
Determining the Impact of a New Physiotherapist Led Primary Care Model for Back Pain: A Pilot Cluster Randomized Controlled Trial
This is a pilot cluster randomized controlled trial to determine the feasibility of a cluster randomized trial to evaluate the individual and health system impact of implementing a new physiotherapist-led primary care model for back pain in Canada.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This study aims to determine the feasibility of conducting a cluster randomized trial in primary care settings in Ontario to evaluate the individual health outcomes and health system impact of implementing a new physiotherapist-led primary care model for people with back pain.
The primary purpose of this pilot study is to determine the feasibility including recruitment and retention of primary care teams (sites) and patient participants, carrying out the assessment procedures, and implementing the physiotherapist-led primary care intervention including training the physiotherapist to adopt this role.
Studietyp
Interventionell
Inskrivning (Faktisk)
100
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Ontario
-
Kingston, Ontario, Kanada, K7L 3N6
- Queen's University
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- Adults (18 years and over) with back pain of any duration
- Seeking primary care for back pain at a participating site
- Primary care visit may be a first or repeat visit
Exclusion Criteria:
- Patients who do not consent to participation
- Patients who report being unable to understand, read, and write English
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Fysioterapeutledd primärvårdsmodell för ryggsmärtor
Den PT-ledda primärvårdsmodellen för ryggsmärta kommer att innebära att en PT införlivas inom primärvårdsteamet vid första kontaktpunkten för personer med ryggsmärta utan kostnad för patienten.
Patienter i denna modell kommer att få välja att träffa PT eller husläkare.
De kommer att uppmuntras att boka med PT förutom när den primära anledningen till besöket är för förnyade läkemedel eller när patienten har ytterligare hälsoproblem som behöver uppmärksammas av sin läkare vid samma besök.
Det kommer att finnas fyra nyckelkomponenter i den PT-ledda primärvårdsinterventionen: 1) Inledande bedömning och screening; 2) Kort individualiserad intervention vid första besöket; 3) Hälsovårdsnavigering; 4) Ge ytterligare PT-vård för personer med ett otillfredsställt behov.
|
|
|
Aktiv komparator: Usual care
The physician led primary care intervention will be unstandardized to best reflect standard clinical practice in Canada.
This usually includes a visit to a primary care physician, who would perform a history and physical examination, provide LBP education, and prescribe medications and/or refer based on their assessment findings and patient preferences.
|
The physician led primary care intervention will be unstandardized to best reflect standard clinical practice in Canada.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Recruitment of primary care teams
Tidsram: Baseline
|
Ability to recruit four primary care teams (Family Health Teams or Community Health Centres) to paricipate
|
Baseline
|
|
Recruitment of patient participants
Tidsram: Baseline to 14 weeks
|
Recruitment rate (participants/week) or total number of participants recruited in 14 weeks
|
Baseline to 14 weeks
|
|
Assessment completion
Tidsram: Baseline, 6-week 12-week, 6,9,12 month follow-up. The primary time point for this assessment is 12-week follow-up.
|
Percentage of all assessment items completed by participants completing each assessment
|
Baseline, 6-week 12-week, 6,9,12 month follow-up. The primary time point for this assessment is 12-week follow-up.
|
|
Retention of patient participants
Tidsram: Retention of participants at 6-week, 12-week, 6, 9, and 12-month follow-up assessments. The primary timeline for this outcome is 12-month follow-up.
|
Attrition rate
|
Retention of participants at 6-week, 12-week, 6, 9, and 12-month follow-up assessments. The primary timeline for this outcome is 12-month follow-up.
|
|
Physiotherapist confidence in carrying out the interventions
Tidsram: Baseline
|
The PT will rate his/her confidence in each component of the intervention after the training on a scale from 0-10 with higher scores indicating greater confidence in carrying out that component of the intervention.
|
Baseline
|
|
Treatment fidelity
Tidsram: 6-week follow-up
|
Treatment fidelity will be measured by consistency with the intervention described in the protocol measured through an intervention checklist completed by the physiotherapist and an audit of the EMR notes.
|
6-week follow-up
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Self-reported disability
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
measured using the Roland Morris Disability Questionnaire (0 to 24 with higher scores indicating greater disability)
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
Self-reported pain intensity
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
measured using a numeric pain rating scale from 0 to 10 with higher scores indicating greater pain intensity (measured at rest, during walking, and during a lifting task)
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
Health Related Quality of Life
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
measured using the EuroQoL-5D-5L (0 to 100 with greater scores indicating greater self-reported health related quality of life)
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
Global rating of change
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
measured using an 11-point scale (-5 to +5 with negative scores indicating a worsening of physical functioning related to back pain and positive scores indicating an improvement of physical functioning related to back pain)
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
Satisfaction with health care
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
measured using an 11-point scale(-5 to +5 with negative scores indicating a dissatisfaction with health care received and positive scores indicating satisfaction with health care received)
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
Catastrophic Thinking
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
measured using the Pain Catastrophizing Scale (0 to 52 with higher scores indicating greater catastrophic thinking)
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
Depressive symptoms
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
measured using the 9-item Patient Health Questionnaire (PHQ-9) (0 to 27 with greater scores indicating increased depressive symptoms)
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
Adverse events
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
measured using an adverse events questionnaire that asks 1) if the patient has experienced any adverse events as a result of the treatments received (yes/no); 2) how long the event lasted (hours or days); 3) how severe the adverse event was (0-10 scale); 4) what adverse events were experienced.
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
Health care accessibility
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
Percentage of patients receiving care within 48 hours.
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
Health care accessibility
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
Percentage of patients who score medium or high risk on the STarT Back tool who receive physiotherapy care.
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
Health care utilization
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
All health care visits (aggregated and dis-aggregated) including: primary care visits, emergency department visits, hospitalizations, surgeries, consultations with other health care providers, diagnostic imaging, medications, and other care received by the patient
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
Costs (piloted for a cost utility analysis in a future trial)
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
Includes all health care costs plus societal costs using a human capital approach for loss of productivity
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
Medications prescribed
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
Measured as a process outcome
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
Diagnostic imaging ordered
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
Measured as a process outcome
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
referrals to other health care providers made
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
Measured as a process outcome
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
|
notes made by primary care provider to employers or insurers
Tidsram: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
Measured as a process outcome
|
Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Jordan Miller, PhD, Queen's University
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
20 september 2017
Primärt slutförande (Faktisk)
15 januari 2019
Avslutad studie (Faktisk)
15 januari 2019
Studieregistreringsdatum
Först inskickad
16 oktober 2017
Först inskickad som uppfyllde QC-kriterierna
24 oktober 2017
Första postat (Faktisk)
25 oktober 2017
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
25 mars 2019
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
21 mars 2019
Senast verifierad
1 mars 2019
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 6021536
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
IPD-planbeskrivning
There is no plan to share individual participant data from this pilot study.
This data will be used to inform the protocol for a fully powered cluster randomized trial.
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Ryggont
-
Hager Montaser Sayed BedeerHar inte rekryterat ännuBack Rolls Assesment | Back Rolls Management
-
Bozok UniversityAvslutad
-
Health Services Academy, Islamabad, PakistanOkändmHälsa | Återintagande | Teach-back kommunikationPakistan
-
University Hospital, GrenobleRekryteringIBD-patienter, Originator Treatment, Biosimilar, Switch BackFrankrike
-
Rush University Medical CenterAvslutadPatientutbildning | Teach-back kommunikation | Efter besöksinstruktioner | PatientförståelseFörenta staterna
-
Medical College of WisconsinChildren's WisconsinAktiv, inte rekryterandeSimulering av fysisk sjukdom | Trakeostomi komplikation | Teach-back kommunikationFörenta staterna
-
Marmara UniversityAvslutadTeach-back kommunikationTurkiet (Türkiye)
-
University of ValenciaAvslutad
-
Future University in EgyptAvslutad
-
Camilo Jose Cela UniversityAvslutadMyofascial Pain Syndrome (MPS)Spanien